Explore more publications!
Aruba Science Wire
Got News to Share?

Aruba Science Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 23, 2025

DriveItAway Holdings Ignites National Scale with Free2move and Launches 9 New Cities in December
December 23, 2025

DriveItAway Holdings Ignites National Scale with Free2move and Launches 9 New Cities in December

Indeterminate GlobeNewswire
Akari Therapeutics Initiates GMP Manufacturing of AKTX-101 ADC Program to Support Phase 1 First-in-Human Clinical Trial
December 23, 2025

Akari Therapeutics Initiates GMP Manufacturing of AKTX-101 ADC Program to Support Phase 1 First-in-Human Clinical Trial

Indeterminate GlobeNewswire
Versus Systems Executes Definitive Agreement with Drinkfinger to Power Global Beverage Engagement Network
December 23, 2025

Versus Systems Executes Definitive Agreement with Drinkfinger to Power Global Beverage Engagement Network

Indeterminate GlobeNewswire
Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones
December 23, 2025

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones

Indeterminate GlobeNewswire
Datacentrex Reports 48% Quarter-Over-Quarter Gross Profit Growth; Revenue Up 27%
December 23, 2025

Datacentrex Reports 48% Quarter-Over-Quarter Gross Profit Growth; Revenue Up 27%

Indeterminate GlobeNewswire
Diginex Provides Update on Acquisition Progress
December 23, 2025

Diginex Provides Update on Acquisition Progress

Indeterminate GlobeNewswire
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
December 23, 2025

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

Indeterminate GlobeNewswire
LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for its State-of-the-Art Test Demonstration Facility located at the K-1330 building on the Historic K-25 Site
December 23, 2025

LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for its State-of-the-Art Test Demonstration Facility located at the K-1330 building on the Historic K-25 Site

Indeterminate GlobeNewswire
VivoPower Announces Strategic Refocus on Power-To-X, With X Being Sovereign AI Compute Infrastructure; Initiates Review of Legacy 682MW Solar Power Development Portfolio
December 23, 2025

VivoPower Announces Strategic Refocus on Power-To-X, With X Being Sovereign AI Compute Infrastructure; Initiates Review of Legacy 682MW Solar Power Development Portfolio

Indeterminate GlobeNewswire
Foresight Expands Road Safety Product Outreach in South Korea with a Strategic Cooperation Agreement
December 23, 2025

Foresight Expands Road Safety Product Outreach in South Korea with a Strategic Cooperation Agreement

Indeterminate GlobeNewswire
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Biometric Identification / Cybersecurity SaaS Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conference Jan. 28 & 29 in Atlantic City, NJ
December 23, 2025

Biometric Identification / Cybersecurity SaaS Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conference Jan. 28 & 29 in Atlantic City, NJ

Indeterminate GlobeNewswire
Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease
December 23, 2025

Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease

Indeterminate GlobeNewswire
OSS Receives Follow-On Production Order from Safran Federal Systems
December 23, 2025

OSS Receives Follow-On Production Order from Safran Federal Systems

Indeterminate GlobeNewswire
Immuneering to Announce 12-Month Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on January 7, 2026
December 23, 2025

Immuneering to Announce 12-Month Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on January 7, 2026

Indeterminate GlobeNewswire
Cassava Announces Agreement to Settle Securities Class Action Litigation
December 23, 2025

Cassava Announces Agreement to Settle Securities Class Action Litigation

Indeterminate GlobeNewswire
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)
December 23, 2025

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Indeterminate GlobeNewswire
ZenaTech Closes Acquisition of Vara 3D, a Utah-Based Surveying and Mapping Firm Expanding Drone-as-a-Service to the High-Growth Solar Infrastructure Market
December 23, 2025

ZenaTech Closes Acquisition of Vara 3D, a Utah-Based Surveying and Mapping Firm Expanding Drone-as-a-Service to the High-Growth Solar Infrastructure Market

Indeterminate GlobeNewswire
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia
December 23, 2025

Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia

Indeterminate GlobeNewswire
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
December 23, 2025

LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions